{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T11:09:30Z","timestamp":1783508970868,"version":"3.55.0"},"reference-count":125,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"McLaughlin Endowment"},{"name":"Kleberg Foundation"},{"name":"NIH","award":["AI127744"],"award-info":[{"award-number":["AI127744"]}]},{"name":"NIH","award":["AI136126"],"award-info":[{"award-number":["AI136126"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.coviro.2019.01.005","type":"journal-article","created":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T14:08:12Z","timestamp":1551967692000},"page":"19-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Strategies for Zika drug discovery"],"prefix":"10.1016","volume":"35","author":[{"given":"Jing","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Yong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2019.01.005_bib0005","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0035-9203(52)90043-6","article-title":"Zika virus. II. Pathogenicity and physical properties","volume":"46","author":"Dick","year":"1952","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.coviro.2019.01.005_bib0010","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1056\/NEJMoa0805715","article-title":"Zika virus outbreak on Yap Island, Federated States of Micronesia","volume":"360","author":"Duffy","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2019.01.005_bib0015","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.3201\/eid2006.140138","article-title":"Zika virus, French polynesia, South Pacific, 2013","volume":"20","author":"Cao-Lormeau","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.coviro.2019.01.005_bib0020","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/jamaophthalmol.2016.0267","article-title":"Ocular findings in infants with microcephaly associated with presumed Zika virus congenital infection in Salvador, Brazil","volume":"134","author":"de Paula Freitas","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.coviro.2019.01.005_bib0025","doi-asserted-by":"crossref","first-page":"917","DOI":"10.15585\/mmwr.mm6534e3","article-title":"Hearing loss in infants with microcephaly and evidence of congenital Zika virus infection \u2013 Brazil, November 2015\u2013May 2016","volume":"65","author":"Leal","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coviro.2019.01.005_bib0030","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2014.19.9.20720","article-title":"Zika virus infection complicated by Guillain-Barre syndrome\u2014case report, French Polynesia, December 2013","volume":"19","author":"Oehler","year":"2014","journal-title":"Euro Surveill"},{"key":"10.1016\/j.coviro.2019.01.005_bib0035","first-page":"747","article-title":"Flaviviruses","volume":"vol 1","author":"Pierson","year":"2013"},{"key":"10.1016\/j.coviro.2019.01.005_bib0040","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1128\/JVI.73.4.3108-3116.1999","article-title":"The serine protease and RNA-stimulated nucleoside triphosphatase and RNA helicase functional domains of dengue virus type 2 NS3 converge within a region of 20 amino acids","volume":"73","author":"Li","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.01.005_bib0045","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1093\/emboj\/21.11.2757","article-title":"An RNA cap (nucleoside-2\u2032-O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization","volume":"21","author":"Egloff","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.coviro.2019.01.005_bib0050","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.1128\/JVI.00814-06","article-title":"West Nile virus 5\u2032-cap structure is formed by sequential guanine N-7 and ribose 2\u2032-O methylations by nonstructural protein 5","volume":"80","author":"Ray","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.01.005_bib0055","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1128\/JVI.02704-06","article-title":"Structure and function of flavivirus NS5 methyltransferase","volume":"81","author":"Zhou","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.01.005_bib0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002642","article-title":"2\u2032-O Methylation of internal adenosine by flavivirus NS5 methyltransferase","volume":"8","author":"Dong","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2019.01.005_bib0065","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nature09489","article-title":"2\u2032-O Methylation of the viral mRNA cap evades host restriction by IFIT family members","volume":"468","author":"Daffis","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2019.01.005_bib0070","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1128\/JVI.02283-06","article-title":"Crystal structure of the dengue virus RNA-dependent RNA polymerase catalytic domain at 1.85-angstrom resolution","volume":"81","author":"Yap","year":"2007","journal-title":"J Virol"},{"issue":"Suppl. 1","key":"10.1016\/j.coviro.2019.01.005_bib0075","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1093\/infdis\/jis761","article-title":"Antiviral resistance and the future landscape of hepatitis C virus infection therapy","volume":"207","author":"Wyles","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2019.01.005_bib0080","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijantimicag.2008.10.010","article-title":"Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV","volume":"33","author":"De Clercq","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.coviro.2019.01.005_bib0085","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.antiviral.2016.03.010","article-title":"Zika virus: history, emergence, biology, and prospects for control","volume":"130","author":"Weaver","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2019.01.005_sbref0090","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.celrep.2016.07.049","article-title":"Broadly neutralizing activity of Zika virus-immune sera identifies a single viral serotype","volume":"16","author":"Dowd","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.coviro.2019.01.005_sbref0095","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-med-040717-051127","article-title":"Zika virus vaccine development: progress in the face of new challenges","volume":"70","author":"Diamond","year":"2019","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.coviro.2019.01.005_sbref0100","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.antiviral.2013.09.013","article-title":"Ten years of dengue drug discovery: progress and prospects","volume":"100","author":"Lim","year":"2013","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2019.01.005_bib0105","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.antiviral.2009.12.011","article-title":"Strategies for development of dengue virus inhibitors","volume":"85","author":"Noble","year":"2010","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2019.01.005_bib0110","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.virol.2016.07.015","article-title":"A robust method for the rapid generation of recombinant Zika virus expressing the GFP reporter gene","volume":"497","author":"Gadea","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2019.01.005_bib0115","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1099\/jgv.0.000938","article-title":"Reverse genetic system, genetically stable reporter viruses and packaged subgenomic replicon based on a Brazilian Zika virus isolate","volume":"98","author":"Mutso","year":"2017","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2019.01.005_bib0120","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00246-16","article-title":"Rescue of the 1947 Zika virus prototype strain with a cytomegalovirus promoter-driven cDNA clone","volume":"1","author":"Schwarz","year":"2016","journal-title":"mSphere"},{"key":"10.1016\/j.coviro.2019.01.005_sbref0125","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.chom.2016.05.004","article-title":"An infectious cDNA clone of Zika virus to study viral virulence, mosquito transmission, and antiviral inhibitors","volume":"19","author":"Shan","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2019.01.005_bib0130","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01114-16","article-title":"A full-length infectious cDNA clone of Zika virus from the 2015 epidemic in Brazil as a genetic platform for studies of virus-host interactions and vaccine development","volume":"7","author":"Tsetsarkin","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.coviro.2019.01.005_bib0135","article-title":"Development and characterization of recombinant virus generated from a new world Zika virus infectious clone","volume":"91","author":"Weger-Lucarelli","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.01.005_bib0140","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02014-16","article-title":"A reverse genetics platform that spans the Zika virus family tree","volume":"8","author":"Widman","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.coviro.2019.01.005_sbref0145","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ebiom.2016.09.013","article-title":"Zika virus replicons for drug discovery","volume":"12","author":"Xie","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.coviro.2019.01.005_bib0150","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jmgm.2016.08.011","article-title":"In-silico screening for anti-Zika virus phytochemicals","volume":"69","author":"Byler","year":"2016","journal-title":"J Mol Graph Model"},{"key":"10.1016\/j.coviro.2019.01.005_bib0155","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.antiviral.2017.04.015","article-title":"Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonists","volume":"143","author":"Shiryaev","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2019.01.005_bib0160","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.antiviral.2017.07.007","article-title":"Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo","volume":"145","author":"Yuan","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2019.01.005_bib0165","doi-asserted-by":"crossref","first-page":"16212","DOI":"10.1021\/jacs.6b10399","article-title":"Structural insight into NS5 of Zika virus leading to the discovery of MTase inhibitors","volume":"138","author":"Stephen","year":"2016","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.coviro.2019.01.005_bib0170","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/jmv.24934","article-title":"Molecular dynamics simulation revealed binding of nucleotide inhibitors to ZIKV polymerase over 444 nanoseconds","volume":"90","author":"Elfiky","year":"2018","journal-title":"J Med Virol"},{"key":"10.1016\/j.coviro.2019.01.005_sbref0175","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.antiviral.2017.12.016","article-title":"Discovery of a non-nucleoside RNA polymerase inhibitor for blocking Zika virus replication through in silico screening","volume":"151","author":"Pattnaik","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2019.01.005_bib0180","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1080\/07391102.2017.1313175","article-title":"Zika virus NS5 protein potential inhibitors: an enhanced in silico approach in drug discovery","volume":"36","author":"Ramharack","year":"2018","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.coviro.2019.01.005_bib0185","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nature17994","article-title":"Structure of the thermally stable Zika virus","volume":"533","author":"Kostyuchenko","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2019.01.005_bib0190","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1126\/science.aaf5316","article-title":"The 3.8 A resolution cryo-EM structure of Zika virus","volume":"352","author":"Sirohi","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.coviro.2019.01.005_bib0195","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nsmb.3352","article-title":"Structure of the immature Zika virus at 9 A resolution","volume":"24","author":"Prasad","year":"2017","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.coviro.2019.01.005_bib0200","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41422-018-0007-9","article-title":"Structural insight into the Zika virus capsid encapsulating the viral genome","volume":"28","author":"Li","year":"2018","journal-title":"Cell Res"},{"key":"10.1016\/j.coviro.2019.01.005_bib0205","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jmb.2018.02.006","article-title":"Crystal structure of the capsid protein from Zika virus","volume":"430","author":"Shang","year":"2018","journal-title":"J Mol Biol"},{"key":"10.1016\/j.coviro.2019.01.005_bib0210","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nature18938","article-title":"Structural basis of potent Zika-dengue virus antibody cross-neutralization","volume":"536","author":"Barba-Spaeth","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2019.01.005_bib0215","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.15252\/embj.201695290","article-title":"Contribution of intertwined loop to membrane association revealed by Zika virus full-length NS1 structure","volume":"35","author":"Xu","year":"2016","journal-title":"EMBO J"},{"key":"10.1016\/j.coviro.2019.01.005_bib0220","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nsmb.3268","article-title":"Extended surface for membrane association in Zika virus NS1 structure","volume":"23","author":"Brown","year":"2016","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.coviro.2019.01.005_bib0225","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1126\/science.aai9309","article-title":"Crystal structure of unlinked NS2B-NS3 protease from Zika virus","volume":"354","author":"Zhang","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.coviro.2019.01.005_bib0230","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1126\/science.aag2419","article-title":"Crystal structure of Zika virus NS2B-NS3 protease in complex with a boronate inhibitor","volume":"353","author":"Lei","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.coviro.2019.01.005_bib0235","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13410","article-title":"Structure of the NS2B-NS3 protease from Zika virus after self-cleavage","volume":"7","author":"Phoo","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2019.01.005_bib0240","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/nsmb.3258","article-title":"Structure of the NS3 helicase from Zika virus","volume":"23","author":"Jain","year":"2016","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.coviro.2019.01.005_bib0245","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.str.2017.06.006","article-title":"Structural dynamics of Zika virus NS2B-NS3 protease binding to dipeptide inhibitors","volume":"25","author":"Li","year":"2017","journal-title":"Structure"},{"key":"10.1016\/j.coviro.2019.01.005_bib0250","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1107\/S2053230X17001601","article-title":"Crystal structure of full-length Zika virus NS5 protein reveals a conformation similar to Japanese encephalitis virus NS5","volume":"73","author":"Upadhyay","year":"2017","journal-title":"Acta Crystallogr F Struct Biol Commun"},{"key":"10.1016\/j.coviro.2019.01.005_bib0255","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14764","article-title":"Crystal structure of Zika virus NS5 RNA-dependent RNA polymerase","volume":"8","author":"Godoy","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2019.01.005_bib0260","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14762","article-title":"Structure and function of the Zika virus full-length NS5 protein","volume":"8","author":"Zhao","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2019.01.005_bib0265","article-title":"The structure of Zika virus NS5 reveals a conserved domain conformation","volume":"8","author":"Wang","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2019.01.005_bib0270","doi-asserted-by":"crossref","first-page":"14830","DOI":"10.18632\/oncotarget.14780","article-title":"The conformational changes of Zika virus methyltransferase upon converting SAM to SAH","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.coviro.2019.01.005_bib0275","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02202-16","article-title":"Zika virus methyltransferase: structure and functions for drug design perspectives","volume":"91","author":"Coutard","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.01.005_sbref0280","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.antiviral.2016.11.018","article-title":"Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay","volume":"138","author":"Adcock","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2019.01.005_sbref0285","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nm.4184","article-title":"Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen","volume":"22","author":"Xu","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2019.01.005_sbref0290","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.chom.2016.07.004","article-title":"A screen of FDA-approved drugs for inhibitors of Zika virus infection","volume":"20","author":"Barrows","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2019.01.005_sbref0295","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.12688\/f1000research.9648.1","article-title":"Zika antiviral chemotherapy: identification of drugs and promising starting points for drug discovery from an FDA-approved library","volume":"5","author":"Pascoalino","year":"2016","journal-title":"F1000Res"},{"key":"10.1016\/j.coviro.2019.01.005_bib0300","doi-asserted-by":"crossref","first-page":"6548","DOI":"10.1128\/JVI.02510-10","article-title":"Inhibition of dengue virus through suppression of host pyrimidine biosynthesis","volume":"85","author":"Wang","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.01.005_bib0305","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.stem.2016.02.016","article-title":"Zika virus infects human cortical neural progenitors and attenuates their growth","volume":"18","author":"Tang","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.coviro.2019.01.005_bib0310","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/cid\/civ949","article-title":"Lovastatin for the treatment of adult patients with dengue: a randomized, double-blind, placebo-controlled trial","volume":"62","author":"Whitehorn","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2019.01.005_bib0315","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.antiviral.2011.05.001","article-title":"Development and characterization of a stable luciferase dengue virus for high-throughput screening","volume":"91","author":"Zou","year":"2011","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2019.01.005_bib0320","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1128\/AAC.49.12.4980-4988.2005","article-title":"High-throughput assays using a luciferase-expressing replicon, virus-like particles, and full-length virus for West Nile virus drug discovery","volume":"49","author":"Puig-Basagoiti","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2019.01.005_sbref0325","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.antiviral.2010.02.313","article-title":"A high-throughput assay using dengue-1 virus-like particles for drug discovery","volume":"86","author":"Qing","year":"2010","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2019.01.005_bib0330","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1128\/JCM.00975-17","article-title":"Evaluation of a novel reporter virus neutralization test for serological diagnosis of Zika and dengue virus infection","volume":"55","author":"Shan","year":"2017","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.coviro.2019.01.005_bib0335","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ebiom.2017.03.006","article-title":"A rapid Zika diagnostic assay to measure neutralizing antibodies in patients","volume":"17","author":"Shan","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.coviro.2019.01.005_bib0340","doi-asserted-by":"crossref","first-page":"20435","DOI":"10.1073\/pnas.0907010106","article-title":"An adenosine nucleoside inhibitor of dengue virus","volume":"106","author":"Yin","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2019.01.005_bib0345","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1007\/s00705-017-3508-9","article-title":"Development of a stable Japanese encephalitis virus replicon cell line for antiviral screening","volume":"162","author":"Zhang","year":"2017","journal-title":"Arch Virol"},{"key":"10.1016\/j.coviro.2019.01.005_bib0350","doi-asserted-by":"crossref","first-page":"12901","DOI":"10.1128\/JVI.77.23.12901-12906.2003","article-title":"Potential high-throughput assay for screening inhibitors of West Nile virus replication","volume":"77","author":"Lo","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.01.005_bib0355","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.antiviral.2007.06.007","article-title":"Construction and characterization of a stable subgenomic dengue virus type 2 replicon system for antiviral compound and siRNA testing","volume":"76","author":"Ng","year":"2007","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2019.01.005_bib0360","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.virol.2004.10.034","article-title":"Construction and applications of yellow fever virus replicons","volume":"331","author":"Jones","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2019.01.005_bib0365","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000476066","article-title":"Generation of a DNA-launched reporter replicon based on dengue virus type 2 as a multipurpose platform","volume":"59","author":"Usme-Ciro","year":"2016","journal-title":"Intervirology"},{"key":"10.1016\/j.coviro.2019.01.005_bib0370","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1099\/vir.0.024083-0","article-title":"Construction of a dengue virus type 4 reporter replicon and analysis of temperature-sensitive mutations in non-structural proteins 3 and 5","volume":"91","author":"Alcaraz-Estrada","year":"2010","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2019.01.005_bib0375","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1128\/jvi.71.2.1497-1505.1997","article-title":"Subgenomic replicons of the flavivirus Kunjin: construction and applications","volume":"71","author":"Khromykh","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.01.005_bib0380","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1099\/vir.0.80677-0","article-title":"Heterologous gene expression by infectious and replicon vectors derived from tick-borne encephalitis virus and direct comparison of this flavivirus system with an alphavirus replicon","volume":"86","author":"Gehrke","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2019.01.005_bib0385","doi-asserted-by":"crossref","first-page":"8745","DOI":"10.1128\/JVI.77.16.8745-8755.2003","article-title":"Stable high-producer cell clone expressing virus-like particles of the Japanese encephalitis virus e protein for a second-generation subunit vaccine","volume":"77","author":"Kojima","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.01.005_bib0390","doi-asserted-by":"crossref","first-page":"11605","DOI":"10.1128\/JVI.78.21.11605-11614.2004","article-title":"trans-Packaged West Nile virus-like particles: infectious properties in vitro and in infected mosquito vectors","volume":"78","author":"Scholle","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.01.005_bib0395","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1590\/0037-8682-0220-2017","article-title":"Development and characterization of a packaging cell line for pseudo-infectious yellow fever virus particle generation","volume":"51","author":"Queiroz","year":"2018","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.coviro.2019.01.005_bib0400","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34865-y","article-title":"High-throughput neutralization assay for multiple flaviviruses based on single-round infectious particles using dengue virus type 1 reporter replicon","volume":"8","author":"Matsuda","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.coviro.2019.01.005_bib0405","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00834-17","article-title":"Development of virus-like-particle vaccine and reporter assay for Zika virus","volume":"91","author":"Garg","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.01.005_bib0410","doi-asserted-by":"crossref","first-page":"8233","DOI":"10.1128\/JVI.00855-15","article-title":"Discovery of dengue virus NS4B inhibitors","volume":"89","author":"Wang","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.01.005_bib0415","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1128\/AAC.01429-12","article-title":"A novel inhibitor of dengue virus replication that targets the capsid protein","volume":"57","author":"Byrd","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2019.01.005_bib0420","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.antiviral.2016.12.016","article-title":"Identification of novel small molecule inhibitors against NS2B\/NS3 serine protease from Zika virus","volume":"139","author":"Lee","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2019.01.005_bib0425","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/cr.2016.116","article-title":"Mechanisms of activation and inhibition of Zika virus NS2B-NS3 protease","volume":"26","author":"Chen","year":"2016","journal-title":"Cell Res"},{"key":"10.1016\/j.coviro.2019.01.005_bib0430","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.2174\/13816128113199990633","article-title":"Drug design for flavivirus proteases: what are we missing?","volume":"20","author":"Poulsen","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.coviro.2019.01.005_bib0435","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.tim.2017.07.001","article-title":"Zika virus protease: an antiviral drug target","volume":"25","author":"Kang","year":"2017","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.coviro.2019.01.005_bib0440","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bmcl.2005.09.049","article-title":"Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitors","volume":"16","author":"Yin","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.coviro.2019.01.005_bib0445","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bmcl.2005.09.062","article-title":"Peptide inhibitors of dengue virus NS3 protease. Part 1: warhead","volume":"16","author":"Yin","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.coviro.2019.01.005_bib0450","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ab.2009.08.013","article-title":"A fluorescence quenching assay to discriminate between specific and nonspecific inhibitors of dengue virus protease","volume":"395","author":"Bodenreider","year":"2009","journal-title":"Anal Biochem"},{"key":"10.1016\/j.coviro.2019.01.005_bib0455","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.antiviral.2012.02.008","article-title":"Retro peptide-hybrids as selective inhibitors of the dengue virus NS2B-NS3 protease","volume":"94","author":"Nitsche","year":"2012","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2019.01.005_bib0460","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1021\/jm300655h","article-title":"Critical effect of peptide cyclization on the potency of peptide inhibitors against dengue virus NS2B-NS3 protease","volume":"55","author":"Xu","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.coviro.2019.01.005_bib0465","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.antiviral.2017.02.002","article-title":"Novel antiviral activity and mechanism of bromocriptine as a Zika virus NS2B-NS3 protease inhibitor","volume":"141","author":"Chan","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2019.01.005_bib0470","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.antiviral.2016.04.014","article-title":"Novel antiviral activity of bromocriptine against dengue virus replication","volume":"131","author":"Kato","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2019.01.005_bib0475","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006411","article-title":"A conformational switch high-throughput screening assay and allosteric inhibition of the flavivirus NS2B-NS3 protease","volume":"13","author":"Brecher","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2019.01.005_bib0480","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1038\/emboj.2008.232","article-title":"Insights into RNA unwinding and ATP hydrolysis by the flavivirus NS3 protein","volume":"27","author":"Luo","year":"2008","journal-title":"EMBO J"},{"key":"10.1016\/j.coviro.2019.01.005_bib0485","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s13238-016-0293-2","article-title":"Structural basis of Zika virus helicase in recognizing its substrates","volume":"7","author":"Tian","year":"2016","journal-title":"Protein Cell"},{"key":"10.1016\/j.coviro.2019.01.005_bib0490","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/jac\/dks147","article-title":"Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug","volume":"67","author":"Mastrangelo","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.coviro.2019.01.005_bib0495","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.antiviral.2011.12.003","article-title":"Use of parallel validation high-throughput screens to reduce false positives and identify novel dengue NS2B-NS3 protease inhibitors","volume":"93","author":"Tomlinson","year":"2012","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2019.01.005_bib0500","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1128\/AAC.02251-12","article-title":"Novel benzoxazole inhibitor of dengue virus replication that targets the NS3 helicase","volume":"57","author":"Byrd","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2019.01.005_bib0505","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.antiviral.2008.07.001","article-title":"Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from dengue virus as a target","volume":"80","author":"Lescar","year":"2008","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2019.01.005_bib0510","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.antiviral.2017.04.017","article-title":"Polysulfonate suramin inhibits Zika virus infection","volume":"143","author":"Tan","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2019.01.005_bib0515","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.antiviral.2013.06.001","article-title":"Development of specific dengue virus 2\u2032-O- and N7-methyltransferase assays for antiviral drug screening","volume":"99","author":"Barral","year":"2013","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2019.01.005_bib0520","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1074\/jbc.M110.179184","article-title":"Small molecule inhibitors that selectively block dengue virus methyltransferase","volume":"286","author":"Lim","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coviro.2019.01.005_bib0525","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.antiviral.2008.08.005","article-title":"A scintillation proximity assay for dengue virus NS5 2\u2032-O-methyltransferase-kinetic and inhibition analyses","volume":"80","author":"Lim","year":"2008","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2019.01.005_bib0530","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ab.2007.09.025","article-title":"A universal competitive fluorescence polarization activity assay for S-adenosylmethionine utilizing methyltransferases","volume":"373","author":"Graves","year":"2008","journal-title":"Anal Biochem"},{"key":"10.1016\/j.coviro.2019.01.005_bib0535","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1021\/acsinfecdis.5b00070","article-title":"Identification and characterization of novel broad-spectrum inhibitors of the flavivirus methyltransferase","volume":"1","author":"Brecher","year":"2015","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.coviro.2019.01.005_bib0540","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.enzmictec.2016.06.010","article-title":"Development of robust in vitro RNA-dependent RNA polymerase assay as a possible platform for antiviral drug testing against dengue","volume":"92","author":"Amraiz","year":"2016","journal-title":"Enzyme Microb Technol"},{"key":"10.1016\/j.coviro.2019.01.005_bib0545","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1128\/AAC.02203-15","article-title":"Identification of a pyridoxine-derived small-molecule inhibitor targeting dengue virus RNA-dependent RNA polymerase","volume":"60","author":"Xu","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2019.01.005_bib0550","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1128\/AAC.00140-10","article-title":"Inhibition of dengue virus RNA synthesis by an adenosine nucleoside","volume":"54","author":"Chen","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2019.01.005_bib0555","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1128\/AAC.00397-10","article-title":"Inhibition of dengue virus by an ester prodrug of an adenosine analog","volume":"54","author":"Chen","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2019.01.005_bib0560","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1665-2681(19)31482-6","article-title":"Balapiravir plus peginterferon alfa-2a (40KD)\/ribavirin in a randomized trial of hepatitis C genotype 1 patients","volume":"11","author":"Nelson","year":"2012","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.coviro.2019.01.005_bib0565","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/infdis\/jis470","article-title":"A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients","volume":"207","author":"Nguyen","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2019.01.005_bib0570","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1128\/JVI.02451-09","article-title":"Inhibition of dengue virus polymerase by blocking of the RNA tunnel","volume":"84","author":"Niyomrattanakit","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.01.005_bib0575","doi-asserted-by":"crossref","first-page":"7934","DOI":"10.1021\/jm901044z","article-title":"N-Sulfonylanthranilic acid derivatives as allosteric inhibitors of dengue viral RNA-dependent RNA polymerase","volume":"52","author":"Yin","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.coviro.2019.01.005_bib0580","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/1087057110389323","article-title":"A fluorescence-based alkaline phosphatase-coupled polymerase assay for identification of inhibitors of dengue virus RNA-dependent RNA polymerase","volume":"16","author":"Niyomrattanakit","year":"2011","journal-title":"J Biomol Screen"},{"key":"10.1016\/j.coviro.2019.01.005_bib0585","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1128\/JVI.00045-13","article-title":"Conformational flexibility of the dengue virus RNA-dependent RNA polymerase revealed by a complex with an inhibitor","volume":"87","author":"Noble","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.01.005_bib0590","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/infdis\/jiw226","article-title":"Nucleoside inhibitors of Zika virus","volume":"214","author":"Eyer","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2019.01.005_bib0595","article-title":"The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication","volume":"7","author":"Sacramento","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.coviro.2019.01.005_sbref0600","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15672","article-title":"A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses","volume":"8","author":"Yu","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2019.01.005_bib0605","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01049-17","article-title":"Monoclonal antibodies against Zika virus: therapeutics and their implications for vaccine design","volume":"91","author":"Wang","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.01.005_sbref0610","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.chom.2018.05.021","article-title":"Zika virus vaccine: progress and challenges","volume":"24","author":"Shan","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"Suppl. 10","key":"10.1016\/j.coviro.2019.01.005_bib0615","doi-asserted-by":"crossref","first-page":"S945","DOI":"10.1093\/infdis\/jix406","article-title":"Small molecules and antibodies for Zika therapy","volume":"216","author":"Xie","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2019.01.005_sbref0620","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved antiviral drugs over the past 50 years","volume":"29","author":"De Clercq","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.coviro.2019.01.005_bib0625","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.tmaid.2018.10.022","article-title":"Zika virus disease in India \u2013 update October 2018","volume":"27","author":"Saxena","year":"2019","journal-title":"Travel Med Infect Dis"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187962571830172X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187962571830172X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:00:41Z","timestamp":1761818441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187962571830172X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":125,"alternative-id":["S187962571830172X"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2019.01.005","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strategies for Zika drug discovery","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2019.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}